Techknowgreen Solutions Ltd Q1 FY26 Earnings Analysis

- The company has grown at about 40%-50% over the past years and expects significant growth to continue. - For the current year and next couple of years, internal targets aim to maintain or exceed this growth, driven by new product commercialization and expansions. - Internationally, bids worth Rs. 5 crores and above are targeted, with recent bids between Rs. 2-3 crores already made in the US and Singapore markets. - Revenue growth is supported by strong order books, with expectations of Rs. 50-70 crores of revenue in the near term. - Key growth areas include commercialization of Yuka Yantra (air pollution control product), Circular Economic Wetland Technology, research lab outputs, and sustainability partnerships, especially with Sterling & Wilson. - The company aims to maintain EBITDA margins above 25-30%, supporting profitable growth.

- Techknowgreen Solutions targets revenue growth around 40%-50% based on past trends. - For FY 2025-26 and next couple of years, management aims to maintain EBITDA margins around 30% or above. - Profit after tax (PAT) margins are targeted around 25%-30%. - Commercialization efforts focus on products like Yuka Yantra (air quality) and CEWT (wastewater technology), with expectations of significant contributions this year. - Research laboratory margins are expected to be high, with 30%+ margins on research projects. - Order book visibility suggests potential revenues of Rs. 50 crores in the coming year. - While there was some margin pressure due to CAPEX and investments (e.g., Rs. 3 crore in lab assets), these are expected to yield profits going forward. - Management aims to sustain profit margins at 30%+ despite scale-up and investments.

- Significant capital investment has been made in setting up the TRL9 Climate Change Laboratory, including computers, plant and machinery, office equipment, furniture, building, vehicles, and software. - Approximately Rs. 3 crore has been invested from cash into laboratory assets during the year. - The company is adding tissue culture expertise to the climate research lab to study impacts on live cells. - Capex investment has temporarily impacted profitability but is expected to generate higher profits going forward. - The company aims to continue investing judiciously, especially towards product development like Yuka Yantra and software. - The business is expanding to international markets with subsidiaries in the USA and Singapore, which involves strategic investments for market entry, registrations, and alignments. - Ongoing alliance and MoU prospects with the Singapore government indicate future strategic research investment opportunities. - The company maintains a target profit margin of 30%+ while balancing these investments.

- The company has not utilized its full sanctioned overdraft limit of Rs. 7.5 crore, indicating available financial flexibility. - They initially planned a preferential share issue but it did not materialize; however, they remain open to raising funds if investors believe in the company. - Ajay Ojha mentioned a willingness to keep asking for money to boost growth, reflecting a propensity to invest judiciously in commercialization opportunities. - Significant investments have been made, especially in the research laboratory (around Rs. 3 crore), funded from cash reserves rather than debt. - The company targets maintaining strong margins (25-30%+ EBITDA) while balancing CAPEX and profitability. - No explicit current or future debt/equity fundraising is confirmed, but there is openness to capital raising aligned with business expansion and investor confidence.

- As of March end 2025, the unexecuted order book (spillover from the previous year) stood around Rs. 23 to 24 crores. - For the first quarter of 2025 (April to June), confirmed work orders (written statements received) amount to Rs. 5 crores. - Pipeline orders (finalized proposals awaiting formal work orders) are approximately Rs. 10 crores by the end of June 2025. - Total expected pipeline order book by June end is therefore around Rs. 15 crores in addition to the Rs. 23 crores spillover. - Execution rate for received orders is roughly 70% within the financial year, with some spillover to the next year's first quarter. - The company is actively bidding, including international bids totaling around Rs. 2 to 3 crores, targeting bids not less than Rs. 5 crores for the current year.